BASEL, Switzerland,
Nov. 29 /PRNewswire/ - BASEL, Switzerland, Nov. 29 / CNW Telbec / Neuro-Biotech Corp.
(PINKSHEET: MRES) (OTCQB: MRES) is pleased to announce that it has
begun the planning and scheduling of a road show for the Company
which is intended to introduce the company to prospective
shareholders in the United
States.
The Company believes that the timing is right
given that a financing is scheduled to close before year end. A
completed financing combined with a clearer picture of the timeline
to commercialization, on their varied products, will enable MRES
management to better represent their potential upside to the
Investment Community. The trip will be focused on
NANOCAP Investment Funds in New
York, Boston, and Los
Angeles.
M. Claude Poulin
md, CEO of MRES, was quoted as saying, The Company has
a clear understanding of what is required and expected in terms of
delivering results. The bar has been set high and it is our
expectation that we will be able to meet our targets in regards to
financing and relevant business development opportunities.
The recent 180˚ change of direction, made by the
large pharmaceutical companies, have motivated management to
commence a well planned strategic "Road Show" in early beginning of
the year 2011.
For more information, do not hesitate to contact
us by using the contact form on our corporate website at
neuro-biotechcorp.com. Your request will be transferred to the
appropriate persons and we will get back to you as soon as
possible.
SOURCE Neuro-Biotech Corp.
Copyright . 29 PR Newswire